cas 2758388-36-0|| where to buy N-[2-(2,6-dioxo-3-piperidyl)-1-oxo-isoindolin-4-yl]-9-(hydroxyamino)-9-oxo-nonanamide

Nombre del producto:N-[2-(2,6-dioxo-3-piperidyl)-1-oxo-isoindolin-4-yl]-9-(hydroxyamino)-9-oxo-nonanamide

IUPAC Name:N'-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-2,3-dihydro-1H-isoindol-4-yl]-N-hydroxynonanediamide

Unidad de embalaje	Stock disponible	Precio($)	Cantidad

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2758388-36-0 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :2758388-36-0; Fórmula molecular:C22H28N4O6; Punto de fusión:-; Código de sonrisas:ONC(=O)CCCCCCCC(=O)NC1=C2CN(C3CCC(=O)NC3=O)C(=O)C2=CC=C1; Densidad:

: Número de catálogo:CM1077513; Peso molecular:444.49; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: PROTAC-E3 Ligase Ligands; Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.; PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules; Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules; PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.